Results 151 to 160 of about 68,932 (288)

Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.

Fertility and Sterility, 2016
Xuefeng Lu, Q. Hong, Lihua Sun, Qiuju Chen, Yonglun Fu, A. Ai, Q. Lyu, Y. Kuang   +7 more
semanticscholar   +1 more source

Rapidly growing extensive polypoid endometriosis after gonadotropin-releasing hormone agonist discontinuation: A case report. [PDF]

World J Clin Cases, 2023
Zhang DY, Peng C, Huang Y, Cao JC, Zhou YF.   +4 more
europepmc   +1 more source

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

The Oncologist, 2015
L. Del Mastro, M. Lambertini
semanticscholar   +1 more source

Final adult height in male patients with central precocious puberty after gonadotropin-releasing hormone agonist treatment. [PDF]

Ann Pediatr Endocrinol Metab
Cho KW, Kim YK, Yoo JE, Kim JY, Kim SJ, Kim S, Choi Y, Song K, Lee EB, Chae HW, Suh J.   +10 more
europepmc   +1 more source

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty. [PDF]

Front Endocrinol (Lausanne), 2023
Tseng CH, Lee YJ, Huang CY, Wu YL, Wang LT, Lin CH, Cheng BW, Lo FS, Chang YJ, Ting WH.   +9 more
europepmc   +1 more source

Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation. [PDF]

Sci Rep, 2023
Han R, Song Z, Li H, Wang C, Zhang L, Yang X.   +5 more
europepmc   +1 more source

Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment. [PDF]

PLoS One
Tanioka S, Asano R, Ota Y, Nagai K, Takenaka K, Mizushima T, Miyagi Y, Miyagi E.   +7 more
europepmc   +1 more source

Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy. [PDF]

ESMO Open, 2023
Massarotti C, Stigliani S, Gazzo I, Lambertini M, Anserini P.   +4 more
europepmc   +1 more source

Outcomes of Patients With Familial Central Precocious Puberty due to Mutations of <i>MKRN3</i> Gene After Treatment With Gonadotropin-Releasing Hormone Agonist. [PDF]

Int J Endocrinol
Chen Z, Li W, Wang J, Dong Z, Li C, Wang W, Hu R, Ma X, Xiao Y, Lu W.   +9 more
europepmc   +1 more source

Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial

Obstetrics and Gynecology, 2015
A. DiVasta, H. Feldman, Jenny Sadler Gallagher, Natalie A. Stokes, M. Laufer, M. Hornstein, C. Gordon   +6 more
semanticscholar   +1 more source